MCMustafa Calik

Mustafa Calik

*This is an algorithmically generated author record based on publicly available information.

Mustafa Calik has a total of 285 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Whole-exome sequencing reveals the neurogenetic spectrum of pediatric epilepsy in Türkiye

    by Mehmet Burak Mutlu, Özlem Öz, Aslıhan Sanrı, Oğuzhan Yaralı, Çağrı Doğan, Özlem Sezer, Mustafa Çalık, Fethiye Kılıçaslan, Özgür Duman, Hakan Gümüş, et al.

  • Open Access

    Pediatrik Baş Ağrıları

    by Ayşe Aksoy, Mine Çiğdem Şenoğlu, Cengiz Dilber, Sedef Terzioğlu Öztürk, İrEm Gökbulak, Ayşegül Danış, Yasemin Baranoğlu Kılınç, Fatma Hancı, Muzaffer Polat, Emine Gülşah Ural, et al.

  • SAĞLIK & BİLİM 2025: Güncel Pediatri-I

    by Mustafa Çalik

    İÇİNDEKİLER/BÖLÜMLER ANNE SÜTÜNÜN İMMÜN SİSTEME VE BAĞIRSAK FLORASINA ETKİLERİ 9 Atilla GÜRAY ANTİBİYOTİK KULLANIMI SONRASI MİKROBİYAL DENGE 19 Ali TUNÇ ÇOCUK SAĞLIĞINDA PREBİYOTİK VE PROBİYOTİKLERİN KULLANIMI 31 Kadir KILIÇ MİKROBİYOTAYI DESTEKLEYEN BESLENME ÖNERİLERİ 45 Tuğçe KALIN GÜNGÖR MİKROBİYOTANIN NÖROGELİŞİMSEL HASTALIKLARDAKİ ROLÜ 71 Uğur TOPÇU AŞILAR VE BAĞIŞIKLIK SİSTEMİ: EFSANELER VE GERÇEKLER 83 Burcu PARLAK SIK TEKRARLAYAN ENFEKSİYONLARDA BAĞIŞIKLIK DEĞERLENDİRMESİ 93 Caner ASLAN ENFLAMATUVAR BAĞIRSAK HASTALIKLARI: ÇOCUKLARDA TANIDAN TAKİBE 107 Enes TURAN PEDİATRİK KARACİĞER HASTALIKLARINDA İNFLAMASYONUN ROLÜ 131 Hatice YILMAZ DAĞLI NEFROTİK SENDROM VE İMMÜN DÜZENLEYİCİ TEDAVİLER 141 Şule PEKTAŞ LEBLEBİCİER PEDİATRİK ROMATOLOJİK HASTALIKLARDA GÜNCEL TEDAVİLER 155 Şeyda DOĞANTAN OTOİNFLAMATUVAR HASTALIKLARIN PEDİATRİK İZLEM PROTOKOLLERİ 167 Hatice Dilara KARAKAŞ PEDİATRİK YAŞ GRUBUNDA COVID-19 VE MIS-C SENDROMU 179 Fırat BEDİR FENİLKETONÜRİNİN TIBBİ BESLENME TEDAVİSİNDE FRUKTOZ TÜKETİMİ, BÜYÜME VE OBEZİTEYE YAKLAŞIM 197 Nihan ÇAKIR BİÇER, Mübeccel DEMİRKOL ÇOCUKLUK ÇAĞINDA OBEZİTE VE METABOLİK İNFLAMASYON 217 Berna SİNGİN ERGENLİK ÖNCESİ DÖNEMDE METABOLİK SAĞLIK VE FİZİKSEL AKTİVİTE 227 Havva Özüm KOLSUZ ÇOCUKLARDA HİPERTANSİYON VE ERKEN VASKÜLER YAŞLANMA 235 Muhammet BULUT ÇOCUKLARDA UYKU BOZUKLUKLARININ BÜYÜME VE BAĞIŞIKLIK ÜZERİNE ETKİLERİ 255 Esra AKYILMAZ ÇOCUKLARDA ANKSİYETE, STRESS VE BAĞIRSAK-BEYİN EKSENİ 269 Orhan COŞKUN ERGENLİK DÖNEMİNDE HORMONAL DEĞİŞİMLER VE ENFLAMASYON 281 Özlem KORKMAZ SAKAOĞLU ÇOCUKLUK ÇAĞI ASTIMI: FENOTİPİK VE ENDOTİPİK SINIFLAMA 293 Zübeyr KAVCAR EKTODERMAL DİSPLAZİ: ORAL REHABİLİTASYON YÖNETİMİNDE PEDİATRİK YAKLAŞIMLAR 305 Müzeyyen Dilşah DEMİRAY, Büşra ALMAS, Halenur ALTAN ÇOCUKLARDA SPOR ÖNCESİ KARDİYAK DEĞERLENDİRME: RİSKTEN KORUNMA VE GÜVENLİ PERFORMANS 321 Hicran Gül EMRAL AİLE EĞİTİMİ VE ÇOCUK SAĞLIĞI SONUÇLARINA ETKİSİ 333 Beyza PEHLİVAN KILIÇ ÇOCUKLARDA EPİGENETİK DEĞİŞİKLİKLER VE ÇEVRESEL FAKTÖRLER 345 Nagehan BİLGEÇ

  • Tonik–Klonik Nöbetlerle Birlikte Olan İdiyopatik Jeneralize Epilepsi Sendromu

    by Ayşe Doğan, Mustafa Çalık

    İdiyopatik jeneralize epilepsiler içinde tek başına jeneralize tonik klonik nöbetlerin görüldüğü jeneralize tonik klonik nöbetli epilepsi sendromu sık görülen bir epilepsi sendromudur. Etkilenen bireyler çoğunlukla ikinci veya erken üçüncü on yılda başlayan, değişen sıklıkta görülen jeneralize tonik–klonik nöbetlere sahiptirler. Genellikle nöbetler uykusuzluk nedeniyle tetiklenir ve hastalarda diğer nöbet türleri ile birlikte görülmez. Öncelikle nöbetleri tetikleyen nedenler, yüksek doz alkol alımı, uykusuzluktan kaçınılması gerektiği hastalara anlatılmalıdır. Bazı hastalarda yaşam biçimini değiştirmek bile nöbetlerin tekrarını engelleyebilir. Tedavide, monoterapide valproik asit ve lamotrijin önerilir.

  • Open Access

    Canpolat, Temel Pediatrik Epilepsi

    by Yiğithan Güzin, Aycan Ünalp, Semra Büyükkorkmaz Öztürk, Müge Ayanoğlu, Fatma Hancı, Esma Şengenç, Sema Saltık, Hatice Hilal Kırkgöz, Burcu Karakayalı, Dilşad Türkdoğan, et al.

  • Evaluation of the Association Among Cerebrospinal Fluid Protein, Inflammatory Markers, and Electromyography in Pediatric Guillain-Barre Syndrome

    by Dilek Agircan, Ozlem Ethemoglu, Mustafa Calik, Tulin Gesoglu Demir

    Evaluation of the Association Among Cerebrospinal Fluid Protein, Inflammatory Markers, and Electromyography in Pediatric Guillain-Barre Syndrome - The Medical Bulletin of Haseki

  • Investigation of Apelin Level and Oxidative Damage in Children Diagnosed with Epilepsy for the First Time

    by Vedat Aksu, Tuba Özgöçer, Hakim Çeli̇k, Mustafa Çalik

    Background: Epilepsy disease, which negatively affects 65 million people around the world, can be seen in all age groups regardless of gender. Disease is known throughout the history of human disease, although the mechanism is still unknown. In this study, it is aimed to investigate of apelin and oxidative stress levels in children with epilepsy. Materials and methods: Children with epilepsy (aged 0-16) who had been diagnosed with epilepsy and did not start treatment were included in the study. This study included control group healthy normal children (n=28) and children with epilepsy group (n=28), totally 56 children were included. Blood samples were removed for apelin, advanced protein oxidation product (AOPP) and DNA damage marker 8-Hydroxy 2-Deoxyguanosine (8-OHdG) levels analyses by ELISA method. Results: Apelin level in generalized type epilepsy was lower than the control group and the complicated febrile group (p<0.05). It has been found that the number of epilepsy seizures is more common in the generalized type epilepsy (p<0.05). While the number of seizures decreased due to the increase in apelin (p=0.05; r=-0.260), it increased due to the increase in AOPP (p=0.05; r=0.264). AOPP was higher in focal type epilepsy than control group. Conclusions: Consequently; 1) Apelin reduced the number of seizures by preventing oxidative DNA damage, 2) Increased the number of seizures by the AOPP increase, 3) As the age rises, the number of seizures has been determined to lower due to decreased in AOPP level.


  • Open Access

    Investigation on Acute Phase Reactants and Oxidant - Antioxidant Parameters in Patients Diagnosed as Having Generalized Tonic Clonic Type Epilepsy on Antiepileptic Monotherapy and Polytherapy

    by Suna Sarikaya, Sedat Yaşi̇n, Mustafa Çalik, Tahir Yoldaş, Nurten Aksoy, Mustafa Yilmaz

    Objective: This study aimed to investigate the relationship between acute-phase reactants and oxidative stress and epilepsy. Methods: The patient group consisted of 67 patients who applied to the Pediatric Neurology outpatient clinic and were diagnosed with generalized type epilepsy according to ILAE classification, 33 were receiving monotherapy and 34 were receiving antiepileptic medication in the form of polytherapy. The control group included 30 healthy volunteer participants with similar sociodemographic characteristics in the same age range, without epilepsy or any known chronic disease. Total anti-Oxidant Status (TAS) and total Oxidant Status (TOS) were measured according to the method developed by Erel, and the oxidative stress index (OSI) was calculated. Sensitive C-reactive protein (Hs-CRP) levels were measured. Results: Both TOS and OSI levels of the patients who received antiepileptic monotherapy and polytherapy were statistically significantly higher than the control group (p = 0.004, the TOS levels of the patients who received antiepileptic monotherapy and polytherapy were 19.29 ± 1.27, 19.22 ± 1.26, respectively, control group 14.49 ± 1.75, OSI levels of patients receiving antiepileptic monotherapy and polytherapy 1.66 ± 0.12, 1.72 ± 0.11, control group 1.27 ± 0.11), respectively. The Hs-CRP level (0.59 ± 0.06 mg / L, 1.09 ± 0.06 mg / L, respectively) of the patients who received monotherapy and polytherapy was statistically significant compared to the control group (0.42 ± 0.02 mg / L) significantly higher. Conclusion: In this study, the findings suggest that epileptic seizures increase oxidative stress parameters and antioxidant mechanisms are insufficient to reduce oxidative damage. In addition, considering the high serum Hs-CRP levels, it is extremely important to develop treatment strategies that can control the inflammatory process in treating resistant epilepsy.


  • Interleukin-33 and oxidative stress in epilepsy patients

    by Ozlem Ethemoglu, Mustafa Calık, Ismail Koyuncu, Kadri Burak Ethemoglu, Adalet Göcmen, Ahmet Güzelcicek, Dursun Cadırcı